Neuroblastoma presented with polyhydramniosis
Serhan Küpeli1, Ali Guliyev, Ali Varan
1Department of Pediatric Oncology, Hacettepe University, Institute of Oncology, Ankara, Turkey. serkupeli@yahoo.com
Pediatric Hematology and Oncology
|August 4, 2010
Summary
A neonate was diagnosed with neuroblastoma, a common pediatric cancer, after atypical symptoms were detected via prenatal ultrasound. This case highlights the importance of prenatal screening for early detection of pediatric solid tumors.
Area of Science:
- Pediatric Oncology
- Medical Imaging in Neonates
Background:
- Neuroblastoma is the most frequent extracranial solid tumor in children.
- Clinical manifestations typically depend on tumor location, disease spread, and paraneoplastic syndromes.
Observation:
- A neonate presented with an unusual clinical picture of neuroblastoma.
- Diagnosis was facilitated by postnatal abdominal ultrasonography.
- The ultrasonography was initially performed due to maternal polyhydramnios during pregnancy.
Findings:
- The study reports a rare case of neonatal neuroblastoma with an atypical presentation.
- Prenatal ultrasonography identified a potential issue, leading to postnatal diagnostic imaging.
- Early detection through ultrasonography was crucial in this neonate.
Implications:
- This case underscores the value of prenatal ultrasonography in identifying potential pediatric tumors.
- Early diagnosis of neonatal neuroblastoma can significantly impact treatment outcomes.
- Highlights the need for considering neuroblastoma in neonates with prenatal findings like polyhydramnios.
Related Concept Videos
01:30Neurulation
Neurulation is the embryological process which forms the precursors of the central nervous system and occurs after gastrulation has established the three primary cell layers of the embryo: ectoderm, mesoderm, and endoderm. In humans, the majority of this system is formed via primary neurulation, in which the central portion of the ectoderm—originally appearing as a flat sheet of cells—folds upwards and inwards, sealing off to form a hollow neural tube. As development proceeds, the anterior...
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...